Literature DB >> 10716470

A decrease in diastolic blood pressure combined with an increase in systolic blood pressure is associated with a higher cardiovascular mortality in men.

A Benetos1, M Zureik, J Morcet, F Thomas, K Bean, M Safar, P Ducimetière, L Guize.   

Abstract

OBJECTIVES: The study evaluated the risk of cardiovascular mortality according to combined spontaneous (non-treatment-related) changes in both systolic and diastolic blood pressure (BP).
BACKGROUND: Long-term longitudinal changes in blood pressure may be a more accurate determinant of cardiovascular risk since changes in systolic or diastolic blood pressure over a period of time reflect the evolution of arterial and arteriolar alterations.
METHODS: Two independent French male cohorts were studied: the IPC cohort (Investigations Préventives et Cliniques) composed of 15,561 men aged 20 to 82 years who had had two visits spaced four to 10 years apart, and the Paris Prospective Study composed of 6,246 men aged 42 to 53 years, examined annually for a period of four years. None of the subjects were taking antihypertensive medication. Annual changes in BP were estimated, and subjects were divided into groups according to the increase, lack of change, or decrease of systolic or diastolic BP. Nine groups were formed by combining the changes of systolic and diastolic BP. Cardiovascular mortality was assessed for a mean period of 13.5 years for the IPC Study and 17 years for the Paris Prospective Study.
RESULTS: In both cohorts, after adjustment for age and major risk factors, the group with an increase in systolic and a decrease in diastolic BP presented the highest relative risk of cardiovascular mortality compared to the group with no changes in either systolic or diastolic BP (relative risk: 2.07 [1.05 to 4.06] in the IPC Study and 2.16 [1.16 to 4.01] in the Paris Prospective Study).
CONCLUSIONS: Assessment of spontaneous changes of BP over a long period of time can contribute to the evaluation of cardiovascular risk. Subjects whose systolic BP increased while their diastolic BP decreased had the highest cardiovascular risk independently of absolute values of BP or other risk factors.

Entities:  

Mesh:

Year:  2000        PMID: 10716470     DOI: 10.1016/s0735-1097(99)00586-0

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  35 in total

Review 1.  Systolic versus diastolic blood pressure versus pulse pressure.

Authors:  William B White
Journal:  Curr Cardiol Rep       Date:  2002-11       Impact factor: 2.931

Review 2.  Pulse pressure: an important tool in cardiovascular pharmacology and therapeutics.

Authors:  Roland Asmar; Michel Safar; Patrice Queneau
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  How genes influence life span: the biodemography of human survival.

Authors:  Anatoliy I Yashin; Deqing Wu; Konstantin G Arbeev; Eric Stallard; Kenneth C Land; Svetlana V Ukraintseva
Journal:  Rejuvenation Res       Date:  2012-05-18       Impact factor: 4.663

Review 4.  Systolic pressure, diastolic pressure, or pulse pressure as a cardiovascular risk factor in renal disease.

Authors:  José A García-Donaire; Luis M Ruilope
Journal:  Curr Hypertens Rep       Date:  2010-08       Impact factor: 5.369

5.  Association of pulse pressure, arterial elasticity, and endothelial function with kidney function decline among adults with estimated GFR >60 mL/min/1.73 m(2): the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Carmen A Peralta; David R Jacobs; Ronit Katz; Joachim H Ix; Magdalena Madero; Daniel A Duprez; Mark J Sarnak; Michael H Criqui; Holly J Kramer; Walter Palmas; David Herrington; Michael G Shlipak
Journal:  Am J Kidney Dis       Date:  2011-10-14       Impact factor: 8.860

6.  Race/ethnic and sex differentials in pulse pressure among us adults.

Authors:  Richard G Rogers; Jarron M Saint Onge
Journal:  Ethn Dis       Date:  2005       Impact factor: 1.847

Review 7.  Future Treatment of Hypertension: Shifting the Focus from Blood Pressure Lowering to Arterial Stiffness Modulation?

Authors:  Henry Fok; J Kennedy Cruickshank
Journal:  Curr Hypertens Rep       Date:  2015-08       Impact factor: 5.369

8.  Retinal microperfusion after renal denervation in treatment-resistant hypertensive patients.

Authors:  Christian Ott; Joanna M Harazny; Axel Schmid; Tilmann Ditting; Roland Veelken; Marek Bladowski; Georg Michelson; Michael Uder; Roland E Schmieder
Journal:  Clin Res Cardiol       Date:  2015-04-28       Impact factor: 5.460

Review 9.  Trials in isolated systolic hypertension: an update.

Authors:  Bernard Waeber
Journal:  Curr Hypertens Rep       Date:  2003-08       Impact factor: 5.369

Review 10.  Trials in isolated systolic hypertension: an update.

Authors:  Bernard Waeber
Journal:  Curr Cardiol Rep       Date:  2003-11       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.